Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Has results × Alemtuzumab × Clear all

Phase

Status

Sponsor Class

OTHER 43 NIH 10 INDUSTRY 3 NETWORK 2 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Kidney Transplantation 1

Interventions

ibritumomab tiuxetan 1 ferric maltol 1 Valganciclovir 1 Tranexamic Acid 1 Tacrolimus 1 Sirolimus 1 Moxibustion 1 Low-Level Light Therapy 1 Infliximab 1 Bevacizumab 1 Alemtuzumab 1 Acupuncture Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02711202 2025-06-04

Sequential Targeting of Cluster of Differentiation 52 (CD52) and Tumor Necrosis Factor (TNF) Allows Early Minimization Therapy in Kidney Transplantation

Institute for Clinical and Experimental Medicine

Phase NA Completed

20 enrolled 11 charts

Kidney Transplantation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡